Liquid Biopsy for Mutation Burden Predicts PFS in NSCLC Immunotherapy – OncLive
OncLive |
Liquid Biopsy for Mutation Burden Predicts PFS in NSCLC Immunotherapy
OncLive A liquid biopsy that measures tumor mutational burden showed promise as an aid for predicting benefit in patients with non–small cell lung cancer (NSCLC) treated with a checkpoint inhibitor, a retrospective analysis of a randomized study showed. |
CBC.ca |
Health Canada investigates Canadian stem cell clinics
CBC.ca The two most common procedures use bone marrow aspirate concentrate or adipose derived stem cells which are removed from a patient’s bone or fat tissue. The extract is placed in a centrifuge and mixed at high speed and then reinjected into the same … |
The Manila Times |
San Diego-based biotech researchers develop stem cell therapy using patient’s own skin cells
The Manila Times Exciting news has reached The Manila Times regarding the latest and most significant breakthrough in the field of stem cell therapy from the United States. Stem cell therapy in its simplest definition is the medical use of stem cells to treat or … Scientists turn human skin cells directly into motor neuronsEconomic Times |
The Manila Times |
San Diego-based biotech researchers develop stem cell therapy using patient’s own skin cells
The Manila Times Exciting news has reached The Manila Times regarding the latest and most significant breakthrough in the field of stem cell therapy from the United States. Stem cell therapy in its simplest definition is the medical use of stem cells to treat or … Scientists turn human skin cells directly into motor neuronsEconomic Times |
Get Surrey |
Style blogger shaves her head to raise vital funds for stem cell treatment for little boy with cerebral palsy
Get Surrey Making a friend in the little boy has helped Miss Miles enormously through her grieving process, so when Enzo’s mum mentioned they hoped to do stem cell treatment to help his condition, she desperately wanted to find a way to help them raise the funds. |
|
Roche to present data on a novel blood-based assay ESMO congress
pharmabiz.com These data have been generated as part of a broad, ongoing effort to advance the personalisation of cancer immunotherapy by delivering treatment options tailored to the specific immune biology associated with a person’s tumour. In pursuit of this goal, … |
|
Roche to present data on a novel blood-based assay ESMO congress
pharmabiz.com These data have been generated as part of a broad, ongoing effort to advance the personalisation of cancer immunotherapy by delivering treatment options tailored to the specific immune biology associated with a person’s tumour. In pursuit of this goal, … |